AI Article Synopsis

  • Hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs) are key players in developing and maintaining the immune system, but their responses to injury and increased cell demand are not fully understood.
  • Research indicates that although HSCs proliferate during inflammation, they may not actually increase their rate of differentiation under stress, contrary to earlier beliefs.
  • Instead, MPPs appear to be the primary contributors to the rapid production of immune cells during challenges like infections, suggesting HSCs may primarily protect themselves rather than actively regenerate the immune system.

Article Abstract

Hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs) generate the immune system in development, and contribute to its maintenance under steady-state conditions. How stem and progenitor cells respond to increased demand for mature cells upon injury is a fundamental question of stem cell biology. Several studies of murine hematopoiesis have reported increased proliferation of HSCs in situ when exposed to inflammatory stimuli, which has been taken as a proxy for increased HSC differentiation. Such surplus generation of HSC may fuel enhanced HSC differentiation or, alternatively, maintain HSC cellularity in the face of increased cell death without enhanced HSC differentiation. This key question calls for direct measurements of HSC differentiation in their natural niches in vivo. Here, we review work that quantifies native HSC differentiation by fate mapping and mathematical inference. Recent differentiation tracing studies show that HSC do not increase their differentiation rate upon a wide range of challenges, including systemic bacterial infection (sepsis), blood loss, and transient or persistent ablation of specific mature immune cells. By contrast, MPPs differentiate more rapidly in response to systemic infection to accelerate the production of myeloid cells. These new in vivo data identify MPPs as a major source of hematopoietic regeneration; HSCs might not contribute to regeneration while remaining protected.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cdev.2023.203861DOI Listing

Publication Analysis

Top Keywords

hsc differentiation
20
differentiation
8
differentiation tracing
8
hematopoietic regeneration
8
multipotent progenitors
8
stem cells
8
hsc
8
enhanced hsc
8
cells
6
tracing identifies
4

Similar Publications

Most blood cells derive from hematopoietic stem cells (HSCs), originating from endothelial cells. The induction of HSCs from endothelial cells occurs during mid-gestation, and research has revealed multiple steps in this induction process. Hemogenic endothelial cells emerge within the endothelium, transition to hematopoietic cells (pre-HSCs), and subsequently mature into functional HSCs.

View Article and Find Full Text PDF

Hematopoietic stem cells (HSCs) reside in a milieu that supports their functions, differentiation, and survival. This niche consists of several types of cells, including mesenchymal stem/stromal cells, endothelial cells, osteoblasts, megakaryocytes, macrophages, adipocytes, lymphoid cells, and nerve fibers. The interactions between these cells and HSCs have a role in HSC fate.

View Article and Find Full Text PDF

Background/objectives: A specialized microenvironment in the bone marrow, composed of stromal cells including mesenchymal stem cells (MSCs), supports hematopoietic stem cell (HSC) self-renewal, and differentiation bands play an important role in leukemia development and progression. The reciprocal direct interaction between MSCs and CD34 HSCs under physiological and pathological conditions is yet to be fully characterized.

Methods: Here, we established a direct co-culture model between MSCs and CD34 HSCs or MSCs and acute myeloid leukemia cells (THP-1, Molm-13, and primary cells from patients) to study heterocellular communication.

View Article and Find Full Text PDF

Thalassaemia, caused by over 250 mutations in the beta globin gene, changes the haematopoietic stem cell (HSC) differentiation, leading to ineffective erythropoiesis. This Wider Perspective article overlooks its underlying nature as a benign HSC disorder with a significant impact on the erythroid cell lineage. The simplicity of managing symptoms through transfusions and iron chelation therapy has shifted the focus away from the development of cell-based treatments.

View Article and Find Full Text PDF

NCF-1 plays a pivotal role in the survival of adenocarcinoma cells of pancreatic and gastric origins.

In Vitro Cell Dev Biol Anim

December 2024

Division of Tumor Pathology, NIR-PIT Research Institute, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka, 573-1010, Japan.

Article Synopsis
  • * The neutrophil cytosolic factor-1 (NCF-1) is identified as a key ROS-generating protein and has been primarily studied in immune cells, but its expression and function in cancer, particularly pancreatic and gastric cancers, was not well understood.
  • * This study found that NCF-1 is highly expressed in pancreatic and gastric cancer cells, where it promotes tumor growth and survival, suggesting that NCF-1-related ROS generation is essential for these cancers, contrary to the typical view of ROS as solely harmful
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

A PHP Error was encountered

Severity: Notice

Message: fwrite(): Write of 34 bytes failed with errno=28 No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 272

Backtrace:

A PHP Error was encountered

Severity: Warning

Message: session_write_close(): Failed to write session data using user defined save handler. (session.save_path: /var/lib/php/sessions)

Filename: Unknown

Line Number: 0

Backtrace: